Physician

Mark L Harrison, MD

According to 2025 Medicare claims, Mark Harrison, MD (NPI: 1417954124) practices radiation oncology in the Brownsville-Harlingen, TX market, with the plurality of this provider's patient population coming from Cameron, TX. This provider's primary affiliated billing organization is VALLEY CANCER ASSOCIATES PA (NPI: 1427233238; TIN: 061831543) and primary practice location at 78550-8912.

Harrison's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 127 traditional Medicare patients, billed 8,008 HCPCS/CPT codes, and received $454,993 in Medicare payments. The top billing code was 78815 (Nuclear medicine study from skull base to mid-thigh with ct scan). Part D data shows 107 prescription claims across 46 beneficiaries totaling $2,072 in drug costs, led by Mometasone Furoate (Mometasone Furoate). Open Payments data shows 34 records totaling $588. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $1,023,946 to $454,993. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $3,181 and ending at $2,072. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$512K$1.0M2015 Medicare payment: $1,023,946 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,006,153 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,020,152 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $659,330 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $834,057 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $792,932 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $577,723 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $525,375 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $423,038 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $454,993 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152676,055$1,023,946
20162605,871$1,006,153
20172645,696$1,020,152
20182253,627$659,330
20192264,456$834,057
20201774,264$792,932
20211852,921$577,723
20221656,422$525,375
20231547,988$423,038
20241278,008$454,993

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$29K$59K2015 Drug cost: $3,181 (USD; Tot_Drug_Cst)2016 Drug cost: $4,001 (USD; Tot_Drug_Cst)2017 Drug cost: $3,026 (USD; Tot_Drug_Cst)2018 Drug cost: $58,671 (USD; Tot_Drug_Cst)2019 Drug cost: $53,124 (USD; Tot_Drug_Cst)2020 Drug cost: $8,820 (USD; Tot_Drug_Cst)2021 Drug cost: $5,328 (USD; Tot_Drug_Cst)2022 Drug cost: $3,396 (USD; Tot_Drug_Cst)2023 Drug cost: $3,535 (USD; Tot_Drug_Cst)2024 Drug cost: $2,072 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201554132$3,181
201663153$4,001
201759142$3,026
201853105$58,671
20193885$53,124
202042106$8,820
20215096$5,328
20224497$3,396
20234488$3,535
202446107$2,072

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
78815Nuclear medicine study from skull base to mid-thigh with ct scan5159$1,207
A9552Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries5866$235
77427Radiation treatment management, 5 treatment sessions29167$145
77334Design and construction of complex radiation treatment device2744$90
Q9967Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml455,600$0

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Mometasone FuroateMometasone Furoate11417$1,001
Ciprofloxacin HclCiprofloxacin Hcl12167$121
Tamsulosin HclTamsulosin Hcl311,260$80

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.34$588Bayer Healthcare Pharmaceuticals Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Mark L. Harrison, MD?

Tedicare shows public-source Medicare data for Mark L. Harrison, MD (NPI 1417954124), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark L. Harrison, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mark L. Harrison, MD?

Mark L. Harrison, MD is linked to VALLEY CANCER ASSOCIATES PA (billing NPI 1427233238) in the available physician profile data.

Does Mark L. Harrison, MD have Open Payments data?

Mark L. Harrison, MD has 34 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.